JAMIL KHURRAM (Chief Medical Officer) sold 7.56K shares of GALECTIN THERAPEUTICS INC on the open market
Open‑market sale worth $23.7K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2026ACC: 0001133416-26-000057
Officer· Chief Medical Officer
Since Aug 2024
-7.56K
Net shares
Net seller
$23.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
7.56K acquired · 15.11K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.56K
Price / share
$1.23
Trade value
$9.30K
% of position
New position
6/23/2026
0.00→7.56K
Common Stock
Direct
Shares
−7.56K
Price / share
$3.14
Trade value
$23.73K
% of position
New position
6/23/2026
7.56K→0.00
Total
Net shares
+0.00
Net value
-$14.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/23/2026 | M · Option Exercise | +7.56K | $1.23 | $9.30K | New position | 0.00 | 7.56K |
| Common Stock Direct | 6/23/2026 | S · Sale | −7.56K | $3.14 | $23.73K | New position | 7.56K | 0.00 |
| Total | +0.00 | -$14.43K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
7.56K shares
Shares
−7.56K
Strike price
1.23
Held after
32.50K
Exercisable
—
6/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock7.56K shares | 6/23/2026 | M · Option Exercise | −7.56K | 1.23 | — | 32.50K |